Protein detail

MET

Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)

Entry name
MET
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
3
Transmembrane count
1
Protein classification
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
Protein Class (11)
Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteinsTransporters
Protein Function (17)
  • Human disease related genes:Cancers:Cancers of the lung and pleura
  • Human disease related genes:Cancers:Cancers of the digestive system
  • Human disease related genes:Nervous system diseases:Ear disease
  • Predicted intracellular proteins
  • ENZYME proteins:Transferases
  • Cancer-related genes:Mutated cancer genes
  • Human disease related genes:Cancers:Cancers of soft tissues and bone
  • RAS pathway related proteins
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
Page 1 of 2
Transmembrane
933..955; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (3)
DFNB97HGFRRCCP2
Gene Description
MET proto-oncogene, receptor tyrosine kinase
Chromosome
7
Position
116672196-116798377
Supporting publications (n)
3
EVMP confidence score
0.38
Fluorescence & Localization7
MET fluorescence
Tissue SpecificintestineBrain Regional Specificbasal gangliaCell SpecificAdipocytesSingle-Nuclei Brain Specificlower rhombic lipBlood Cell SpecificneutrophilBlood Lineage Specificgranulocytes
Function & Pathway7
Protein Function (17)
  • Human disease related genes:Cancers:Cancers of the lung and pleura
  • Human disease related genes:Cancers:Cancers of the digestive system
  • Human disease related genes:Nervous system diseases:Ear disease
  • Predicted intracellular proteins
  • ENZYME proteins:Transferases
  • Cancer-related genes:Mutated cancer genes
  • Human disease related genes:Cancers:Cancers of soft tissues and bone
  • RAS pathway related proteins
  • Enzymes
  • Cancer-related genes:Candidate cancer biomarkers
Page 1 of 2
Mediation Categories (4)
Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence242

Enzyme-Mediated Modification (71)

71 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
METPRKCDQ05655S985phosphorylationProtMapperKEAphosphoELMPhosphoSitePhosphoSite_ProtMapperKEA:7925482KEA:8294430phosphoELM:15075332KEA:15075332KEA:94124523
METPRKCDQ05655S1,003phosphorylationMIMPHPRD_MIMPphosphoELM_MIMPPhosphoSite_MIMP
METPRKCEQ02156S985phosphorylationBEL-Large-Corpus_ProtMapperProtMapperKEAphosphoELMPhosphoSitePhosphoSite_ProtMapperKEA:7925482ProtMapper:15212693KEA:8294430phosphoELM:15075332KEA:15075332KEA:94124523
METPRKCEQ02156S1,003phosphorylationMIMPHPRD_MIMPphosphoELM_MIMPPhosphoSite_MIMP
METPTPN2P17706Y1,235dephosphorylationSIGNORDEPODSIGNOR:18819921DEPOD:18819921
METPTPN2P17706Y1,234dephosphorylationSIGNORDEPODSIGNOR:18819921DEPOD:18819921
METPTPN2P17706Y1,356phosphorylationNCI-PID_ProtMapperProtMapperProtMapper:18819921
METPTPN2P17706Y1,234phosphorylationNCI-PID_ProtMapperSIGNOR_ProtMapperReactome_ProtMapperProtMapperProtMapper:18819921
METPTPN2P17706Y1,349phosphorylationNCI-PID_ProtMapperProtMapperProtMapper:18819921
METPTPN2P17706Y1,235phosphorylationNCI-PID_ProtMapperSIGNOR_ProtMapperReactome_ProtMapperProtMapperProtMapper:18819921
Page 1 of 8Next

Ligand-Receptor Signaling (61)

61 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularOmniPathNoNoYesYesNo
cell_adhesioncell_adhesionCellinkerYesYesYesYesNo
adhesionadhesionOmniPathYesYesYesYesNo
cell_adhesioncell_adhesionOmniPathYesYesYesYesNo
transmembranetransmembraneUniProt_locationNoNoYesYesNo
transmembranetransmembraneUniProt_topologyNoNoYesYesNo
transmembranetransmembraneUniProt_keywordNoNoYesYesNo
transmembrane_predictedtransmembraneOmniPathNoNoYesYesNo
transmembranetransmembraneGO_IntercellNoNoYesYesNo
transmembranetransmembraneCellPhoneDBNoNoYesYesNo
Page 3 of 7PreviousNext

Regulatory Interaction Network (28)

28 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
HGFP14210METP08581YesYesNoiTALKKEGG-MEDICUSGuide2Pharma_LRdbICELLNETProtMapperSIGNORHINTSignaLink3UniProt_LRdbDIPLit-BM-17HPMR_talklrCellChatDBHPRD_LRdbDLRP_CellinkertalklrscConnectHPRDCui2007IntActDLRP_talklrGuide2Pharma_CellinkerWangRamilowski2015BEL-Large-Corpus_ProtMapperHPMR_LRdbCellPhoneDBGuide2Pharma_talklrHPRD_talklrBioGRIDCellinkerREACH_ProtMapperSTRING_talklrCellCallGuide2PharmaCellTalkDBFantom5_LRdbSparser_ProtMapperHPMR_CellinkerconnectomeDB2020SPIKE_LCLRdbSPIKECellinker:15167892LRdb:1846706ProtMapper:24362531Lit-BM-17:17804794ProtMapper:27147579HINT:15167892DIP:16537482SPIKE_LC:17145710DIP:20624990HPRD:1655405HINT:17804794SIGNOR:8380735HINT:15161915SPIKE:17145710HINT:8380735Lit-BM-17:17981115ProtMapper:22001117IntAct:17804794SPIKE_LC:14685170Cellinker:28475121Cellinker:18495663HPRD:15167892ProtMapper:16397249IntAct:20624990SignaLink3:8380735LRdb:1655405Cellinker:1655405HINT:23882082IntAct:1846706connectomeDB2020:1655405HPRD:18495663IntAct:22897854LRdb:18495663Lit-BM-17:22897854HINT:24859116Lit-BM-17:15167892HINT:17981115ProtMapper:28534512connectomeDB2020:1846706CellTalkDB:1846706Lit-BM-17:1846706connectomeDB2020:18495663connectomeDB2020:15167892SignaLink3:23331499IntAct:15167892SPIKE_LC:1846706CellChatDB:28475121Cellinker:1846706ProtMapper:34064863ProtMapper:17667909ICELLNET:15218027HINT:34210960BioGRID:1655405Lit-BM-17:19433454IntAct:17981115ProtMapper:20178463SIGNOR:37450419Lit-BM-17:8380735SPIKE:14685170SPIKE:1846706LRdb:15167892IntAct:16537482DIP:17804794
METP08581SHC1P29353YesYesNoSPIKEWangphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointProtMapperHPRDLi2012SPIKE_LCLit-BM-17PhosphoSitePhosphoSite_ProtMapperPhosphoSite:11687594SPIKE_LC:14685170Lit-BM-17:24728074PhosphoSite:14990987PhosphoSite:15688026PhosphoSite:9083103Lit-BM-17:9660480PhosphoSite:8084588PhosphoSite:8939605SPIKE:14685170PhosphoSite:8947042PhosphoSite:11884620HPRD:7731718
METP08581GAB1Q13480YesYesNoSPIKEKEGG-MEDICUSHPRD_MIMPSIGNORProtMapperHINTPhosphoSite_KEAphosphoELM_KEALi2012PhosphoNetworksHPRDCui2007Kinexus_KEAWangBEL-Large-Corpus_ProtMapperphosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetPhosphoPointKEAHPRD_KEAphosphoELMSIGNOR_ProtMapperSPIKE_LCHPRD-phosHPRD-phos:18669648KEA:11779868KEA:15574420HPRD-phos:10978177KEA:10978177SPIKE_LC:14685170ProtMapper:15212693SIGNOR:10734310HINT:10913131ProtMapper:17016520HPRD-phos:20068231HPRD-phos:10734310SPIKE:10913131KEA:10734310ProtMapper:17389395KEA:9890893ProtMapper:10734310HINT:11894096ProtMapper:10978177HPRD:10995442KEA:10753869HPRD-phos:19901323HPRD-phos:17389395HPRD:10734310ProtMapper:16497976ProtMapper:19901323KEA:11896055phosphoELM:10734310SPIKE_LC:10913131ProtMapper:20068231HPRD-phos:16497976ProtMapper:18669648SPIKE:14685170HPRD-phos:17016520
CBLP22681METP08581YesYesYesDOMINOWangSparser_ProtMapperNCI-PID_ProtMapperSIGNORProtMapperREACH_ProtMapperHPRDHINTSignaLink3BioGRIDACSNIntActLMPIDSPIKE_LCLit-BM-17HINT:15123609HINT:21163258Lit-BM-17:21163258ACSN:17635922IntAct:18273061SignaLink3:16397241IntAct:21163258SignaLink3:19450681BioGRID:17533376IntAct:25241761HPRD:11894096LMPID:15123609Lit-BM-17:18273061BioGRID:19450681Lit-BM-17:21222362SIGNOR:19450681HINT:18273061SPIKE_LC:11894096ProtMapper:18672314ProtMapper:11741535SignaLink3:18273061ACSN:10514377BioGRID:35309168Lit-BM-17:11894096Lit-BM-17:19450681Lit-BM-17:16397241HINT:11894096ProtMapper:20331976SignaLink3:15123609HINT:21222362SignaLink3:23331499DOMINO:11894096Lit-BM-17:25241761SignaLink3:11894096Lit-BM-17:15123609Lit-BM-17:19433454IntAct:11894096ProtMapper:17635922HPRD:18273061
METP08581GLMNQ92990YesYesYesPhosphoPointSIGNORHPRDSignaLink3Lit-BM-17Lit-BM-17:11571281SIGNOR:11571281SignaLink3:23331499HPRD:11571281SignaLink3:11571281
METP08581GRAPQ13588YesYesNoSIGNORSignaLink3SIGNOR:8662889SignaLink3:8662889SignaLink3:23331499
METP08581RANB9Q96S59YesYesNoWangPhosphoPointSIGNORHPRDSignaLink3SPIKE_LCLit-BM-17SIGNOR:12147692HPRD:12147692Lit-BM-17:12147692SPIKE_LC:12147692SignaLink3:12147692SignaLink3:23331499
PTPRJQ12913METP08581YesNoYesWangNCI-PID_ProtMapperSIGNORProtMapperDEPODHPRDHINTReactome_ProtMapperKEAKinexus_KEAIntActSIGNOR_ProtMapperHPRD-phosHINT:12475979IntAct:12475979SIGNOR:12475979IntAct:19167335KEA:15475459HPRD:12370829ProtMapper:12475979HPRD-phos:12370829DEPOD:12475979
PTN1P18031METP08581YesNoYesWangNCI-PID_ProtMapperSIGNORProtMapperDEPODHINTReactome_ProtMapperIntActSIGNOR_ProtMapperLit-BM-17SPIKE_LCSIGNOR:29920310HINT:18579758DEPOD:18819921HINT:16537444Lit-BM-17:22789536SIGNOR:18819921IntAct:22789536SIGNOR:16537444IntAct:16537444IntAct:18579758Lit-BM-17:16537444ProtMapper:16537444ProtMapper:18819921SPIKE_LC:16537444Lit-BM-17:18579758
METP08581CAV1Q03135YesYesNoSIGNORSIGNOR:25148256
Page 1 of 3Next

Protein Complex Composition (81)

81 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
HGF-Met complexHGFMETP08581P142102:2CompleatCORUMPDBPDB:4k3jPDB:1shyPDB:4o3uPDB:7mo7PDB:7mo8PDB:7mobCORUM:2541PDB:7moaPDB:4o3tPDB:7mo9Compleat:HC326215161915
MET-CIN85-SH3GL3-CBL complexHGF stimulatedCBLMETSH3GL3SH3KBP1P08581P22681Q96B97Q999631:1:1:1CompleatCORUMCompleat:HC2699CORUM:245611894096
Methyltransferase complexMETTL3-METTL14METTL14METTL3Q86U44Q9HCE51:1ComplexPortalPDBPDB:7oegPDB:6ttwPDB:5l6ePDB:7oemPDB:7O0MPDB:7oqoPDB:7oejPDB:7o0qPDB:7o27PDB:7nidPDB:7rx8PDB:7nhiPDB:7niaPDB:7acdPDB:9g4wPDB:9g4sPDB:7o2fPDB:8bn8PDB:7nhjPDB:5l6dPDB:5k7mPDB:5K7MPDB:7o0pPDB:5K7UPDB:5il2PDB:7oedPDB:6y4gPDB:8pwbPDB:7rx7PDB:9g4uPDB:6ttxPDB:7rx6PDB:5il1PDB:7oeePDB:7nhvPDB:7o2hPDB:7o2iPDB:7oelPDB:7oqlPDB:7o0mPDB:7ni7PDB:5k7wPDB:5TEYPDB:7o0rPDB:6ttvPDB:7oqpPDB:7o28intact:EBI-58912060PDB:5il0PDB:6tu1PDB:7oekPDB:7oeiPDB:7oefPDB:8PWAPDB:7nhgPDB:7o08PDB:5IL0PDB:7OEKPDB:7o0lPDB:7O0LPDB:6tttPDB:7ni8PDB:7o09PDB:7ni9PDB:7oehPDB:6ttpPDB:5k7uPDB:7o2ePDB:8pwaPDB:7o2xPDB:8PW9PDB:8PW8PDB:5teyPDB:7o29PDB:7nhhPDB:8pw93835548338470714243167153734928414755292
tRNA Methyltransferase ComplexMETTL1WDR4P57081Q9UBP61:1CompleatComplexPortalPDBPDB:8eg0PDB:8cthCompleat:HC594PDB:8ctiPDB:8h0nintact:EBI-12560184PDB:8d9kPDB:7u20PDB:8d58PDB:8d9l124034641475529236599985
ATG4CGLUD2KLHL22METTL15RBFASCARF2SDHAF1SRGAP1A6NFY7A6NJ78P49448Q53GT1Q7Z6B7Q8N0V3Q96DT6Q96GP60:0:0:0:0:0:0:0hu.MAP2
ATG4CGLUD2KLHL22METTL15RBFASCAF8SCARF2SDHAF1SRGAP1A6NFY7A6NJ78P49448Q53GT1Q7Z6B7Q8N0V3Q96DT6Q96GP6Q9UPN60:0:0:0:0:0:0:0:0hu.MAP2
AURKAIP1DAP3METTL15MRPS10MRPS11MRPS12MRPS14MRPS15MRPS16MRPS17MRPS18BMRPS18CMRPS2MRPS21MRPS22MRPS23MRPS24MRPS25MRPS26MRPS27MRPS28MRPS31MRPS33MRPS34MRPS35MRPS5MRPS6MRPS7MRPS9PTCD3RBFAA6NJ78O15235O60783P51398P82650P82663P82664P82673P82675P82912P82914P82921P82930P82932P82933Q8N0V3Q92552Q92665Q96EL2Q96EY7Q9BYN8Q9NWT8Q9Y291Q9Y2Q9Q9Y2R5Q9Y2R9Q9Y399Q9Y3D3Q9Y3D5Q9Y3D9Q9Y6761:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1PDBPDB:9g5cPDB:7pnzPDB:7pnxPDB:9g5dPDB:7pny
AURKAIP1DAP3METTL15MRPS10MRPS11MRPS12MRPS14MRPS15MRPS16MRPS17MRPS18BMRPS18CMRPS2MRPS21MRPS22MRPS23MRPS24MRPS25MRPS26MRPS27MRPS28MRPS31MRPS33MRPS34MRPS35MRPS5MRPS6MRPS7MRPS9PTCD3A6NJ78O15235O60783P51398P82650P82663P82664P82673P82675P82912P82914P82921P82930P82932P82933Q92552Q92665Q96EL2Q96EY7Q9BYN8Q9NWT8Q9Y291Q9Y2Q9Q9Y2R5Q9Y2R9Q9Y399Q9Y3D3Q9Y3D5Q9Y3D9Q9Y6761:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1PDBPDB:8qrl
METTL15RBFAA6NJ78Q8N0V31:1hu.MAP2PDBPDB:8iplPDB:8ipm
GTPBP1METTL16NFYAPLCB3O00178P23511Q01970Q86W500:0:0:0hu.MAP
Page 1 of 9Next

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyImmunoaffinity CaptureMass spectrometry6381133683732247540189497361468343180595838207106
Sequence, Structure & Domains14

Sequences

Length
1,390
Mass
155,541
Sequence
MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECILTEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVDTRPASFWETS
Alternative Products
Event=Alternative splicing; Named isoforms=3; Comment=Additional soluble isoforms seem to exist.; Name=1; IsoId=P08581-1; Sequence=Displayed; Name=2; IsoId=P08581-2; Sequence=VSP_005005; Name=3; Synonyms=Soluble MET variant 4; IsoId=P08581-3; Sequence=VSP_042447, VSP_042448
Alternative Sequence
755..764; SGGSTITGVG -> RHVNIALIQR (in isoform 3); 755; S -> STWWKEPLNIVSFLFCFAS (in isoform 2); 765..1390; Missing (in isoform 3)

3D Structural Models

Turn
75..77; 242..244; 395..397; 429..436; 496..498; 1172..1174; 1227..1230; 1239..1241; 1354..1358
Helix
25..30; 103..105; 205..208; 231..233; 239..241; 327..333; 367..374; 380..382; 387..390; 520..522; 526..529; 534..536; 548..550; 614..616; 1048..1050; 1055..1057; 1060..1066; 1067..1069; 1073..1075; 1118..1132; 1165..1170; 1178..1197; 1207..1209; 1224..1226; 1232..1234; 1247..1249; 1252..1257; 1262..1277; 1289..1291; 1292..1297; 1310..1319; 1324..1326; 1330..1342
Beta Strand
45..47; 52..58; 61..66; 69..74; 80..84; 89..91; 93..95; 97..99; 111..113; 119..123; 125..133; 135..139; 141..145; 155..160; 166..168; 173..175; 182..189; 192..199; 213..219; 247..255; 258..268; 272..274; 277..281; 284..286; 292..300; 312..314; 316..323; 341..349; 356..366; 383..385; 392..394; 418..422; 424..427; 439..447; 450..457; 462..466; 469..471; 476..480; 490..493; 501..506; 509..514; 539..541; 544..546; 552..554; 557..559; 564..574; 580..586; 589..592; 595..598; 602..605; 619..625; 633..641; 646..655; 658..663; 665..668; 674..681; 688..692; 698..702; 704..710; 718..726; 729..739; 1076..1087; 1090..1098; 1100..1102; 1104..1111; 1144..1146; 1149..1151; 1154..1158; 1161..1163; 1210..1212; 1218..1220; 1235..1237; 1244..1246; 1283..1287
3D Structure
Electron microscopy (5); NMR spectroscopy (1); X-ray crystallography (114)

Domain & Motif Annotations

Domain (CC)
The kinase domain is involved in SPSB1 binding.; DOMAIN: The beta-propeller Sema domain mediates binding to HGF.
Domain (FT)
27..515; Sema; 563..655; IPT/TIG 1; 657..739; IPT/TIG 2; 742..836; IPT/TIG 3; 1078..1345; Protein kinase
Region
1212..1390; Interaction with RANBP9; 1320..1359; Interaction with MUC20
Protein Families (2)
  • Protein kinase superfamily
  • Tyr protein kinase family
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family.
Clinical Relevance9
Disease Involvement (6)
Cancer-related genesDeafnessDisease variantFDA approved drug targetsNon-syndromic deafnessProto-oncogene
Biomarker
Phase 1/2; Phase 2; Phase 1; Phase 3; Discontinued in Phase 2; Approved; Preclinical
Drug Targets
FDA approved drug targets
Drugs (101)
FORETINIBGEFITINIBSELUMETINIBTIVANTINIBTEPOTINIBCABOZANTINIB S-MALATEOSIMERTINIBGLESATINIBANTI-MET MONOCLONAL ANTIBODY MIXTURE SYM015CAPMATINIBCETUXIMABROCILETINIBEMIBETUZUMABCHEMBL:CHEMBL546797BMS-754807BMS-777607NULLCEP-11981-SAR 125844.00DACTOLISIBTEREVALEFIMAMG-208PEMBROLIZUMABEUCALYPTIN AMACROCARPAL BMET TYROSINE KINASE INHIBITOR SGX523MITOGEN-ACTIVATED PROTEIN KINASE KINASE INHIBITORBMS-794833PF-04217903SAVOLITINIBTRAMETINIB DIMETHYL SULFOXIDEOLEOCANTHALEMB-01TAS-115VEMURAFENIBTELISOTUZUMABZM447439C-MET INHIBITOR AMG 208CRIZOTINIBCAPMATINIB HYDROCHLORIDESITRAVATINIBMK-8033MK-2461GALLOCATECHIN GALLATEEMD-1204831TELISOTUZUMAB VEDOTINPF-562271TEPOTINIB HYDROCHLORIDEBMS-698769ALTIRATINIBNVP-TAE684ONARTUZUMABEPIGALLOCATECHIN-3-GALLATECMX-2043PD-0166285SP-600125YUANHUADINELAPATINIBSU11274BMS-817378AMG-337PAZOPANIBMERESTINIBPHA-665752PALBOCICLIBCP-547632ERLOTINIBSGX-523JNJ-38877605AMUVATINIBANTI-C-MET MONOCLONAL ANTIBODY SAIT301CHEMBL:CHEMBL1997335MACROCARPAL AGOLVATINIBENTRECTINIBBEPERMINOGENE PERPLASMIDANTI-MET/EGFR MONOCLONAL ANTIBODY LY3164530TAMATINIBCHEMBL:CHEMBL399530CRENOLANIBRITUXIMABSNS-314C-MET INHIBITOR MK2461C-MET INHIBITOR AMG 337PANITUMUMABC-MET INHIBITORARRY-300BPI-9016ILORASERTIBTYROSOL SINAPATECENISERTIBCYC-116EPICATECHIN GALLATENINGETINIBAPRATOXIN FAMIVANTAMAB-VMJWLINIFANIBANTI-EGFR MONOCLONAL ANTIBODYVEBRELTINIBBAY 61-3606JNJ-7706621
Interaction Protein (6)
ENSG00000010017ENSG00000019991ENSG00000103423ENSG00000110395ENSG00000146648ENSG00000197122
Interaction Count
6
Interaction Dataset
intact_biogrid
Supporting Publications3
PMIDTitleAbstract
29889559Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury.Tau, p-tau, Aβ40, and Aβ42 were measured by ultrasensitive immunoassay in plasma and exosomes from 195 Veterans enrolled in the Chronic Effects of Neurotrauma Consortium Multicenter Observational Study.
37673813Assessment of Risk Factors for Postoperative Delirium in Older Adults Who Underwent Spinal Surgery and Identifying Associated Biomarkers Using Exosomal Protein.To discover the biomarkers, urine extracellular vesicles (EVs) were analyzed for tau, ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), neurofilament light, and glial fibrillary acidic protein using digital immunoassay technology.
38257772CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV.Given the role of extracellular vesicles (EVs) in age-related neurological disorders, we investigated soluble and EV-associated Aβ42, total Tau, NFL, GFAP, ICAM-1, VCAM-1, and CRP in relation to cognitive impairment in PWH.